Clinical • P1 data • Clinical Trial,Phase I • Journal • Combination therapy • PD(L)-1 Biomarker • IO biomarker • Metastases
|
MSI (Microsatellite instability) • CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • IL17A (Interleukin 17A)
|
Opdivo (nivolumab) • enadenotucirev (ColoAd1)